QA: vTv Therapeutics Inc in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001641489_2025_vTv_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001641489, vTv Therapeutics Inc

  xvar xval
0 AssetsCurrent 38,113,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 28,000
3 remainder_Assets 125,000
4 LiabilitiesCurrent 5,196,000
5 LiabilitiesNoncurrent 18,669,000
6 remainder_Liabilities 100,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 13,655,221
9 ResearchAndDevelopmentExpense 10,010,920
10 remainder_Expenses 71,268
11 remainder_Revenues 611,434
12 remainder_NetIncome 692,240
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 38,266,000
1 Liabilities 23,965,000
2 Expenses 23,737,409
3 Revenues 611,434
4 StockholdersEquity 14,301,000
5 NetIncome -22,433,735
6 ComprehensiveNetIncome -22,433,735
7 BaseVar 43,636,042
8 EconomicCapitalRatiobeforeLimitedLiability 0.281
9 EconomicCapitalRatio 1.68

Edgar->Model Mapping

Feature Distribution

Change over Time